Loading provider…
Loading provider…
Dermatology Physician in Sacramento, CA
NPI: 1013332451Primary Practice Location
Pacific Skin Institute
1495 River Park Dr, Sacramento, CA
Primary Employer
PACIFIC SKIN INSTITUTE
HQ Phone
Get Jennifer's Phone Numberphone_androidMobile
Get Jennifer's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2017 - 2027
NC State Medical License
2016 - 2017

American Board of Dermatology
Dermatology

American Board of Dermatology
Pediatric Dermatology
Wake Forest University Baptist Medical Center
Residency • Internal Medicine
2015 - 2018
UC Davis School of Medicine
health.ucdavis.edu
Medical School
Until 2015
University of California Davis Health
Residency • Dermatology
2017 - 2020
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 63 | 91 |
| 2 | 17000Destruction of skin growth | 25 | 30 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 25 | 31 |
| 4 | 17110Destruction of up to 14 skin growths | 20 | 23 |
| 5 | 17003Destruction of 2-14 skin growths | 20 | 94 |
Cedarwood Oil as Complementary Treatment in Refractory Acne.
Authors: Lauren Hassoun, Raja Sivamani
Publication Date: 2016-02-24
Anogenital warts and relationship to child sexual abuse: Systematic review and meta-analysis.
Authors: April Armstrong, Daniel Eisen, Smita Awasthi
Journal: Pediatr Dermatol
Publication Date: 2021-06-01
International inter-rater agreement in scoring acne severity utilizing cloud-based image sharing of mobile phone photographs
Authors: Mirza Alikhan, Smita Awasthi, Ifrah Ali
Lead Sponsor: Eli Lilly and Company
Collaborators: Dermira, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Lebrikizumab, DRUG: Topical Corticosteroid (TCS)